Certolizumab (anti-TNFa) 是重组人源化单克隆抗体的 Fab 片段,针对促炎细胞因子肿瘤坏死因子-α (TNF-α),具有抗炎活性。
Certolizumab (anti-TNFa) is a Fab fragment of a recombinant, humanized monoclonal antibody directed against the proinflammatory cytokine tumor necrosis factor-alpha (TNF-alpha) with anti-inflammatory activity. Purity ≥95% (SDS-PAGE&SEC) Endotoxin Level < 1.0EU/mg
规格
产品名称
Recombinant TNF-alpha Antibody
别名
赛妥珠单抗
英文别名
APC1 antibody|APC1 protein antibody|Cachectin antibody|DIF antibody|Differentiation inducing factor antibody|Macrophage cytotoxic factor antibody|Tnf antibody|TNF superfamily member 2 antibody|TNF superfamily, member 2 antibody|TNF, macrophage derived antibody|TNF, monocyte derived antibody|TNF-a antibody|TNF-alpha antibody|TNFA antibody|TNFSF2 antibody|Tumor necrosis factor (TNF superfamily member 2) antibody|Tumor necrosis factor alpha antibody|Tumor necrosis factor antibody|Tumor necrosis factor ligand superfamily member 2 antibody|Tumor Necrosis Factor, Membrane Form antibody|Tumor necrosis factor, soluble form antibody|APC1 protein|Cachectin|Cachetin|DIF|TNF|TNF, monocyte-derived|TNFA|TNF-A|TNFalpha|TNF-alpha|TNF-alphacachectin|TNFATNF, macrophage-derived|TNFG1F|TNFSF1A|TNFSF2|TNFSF2TNF superfamily, member 2|tumor necrosis factor (TNF superfamily, member 2)|tumor necrosis factor alpha|Tumor necrosis factor ligand superfamily member 2|tumor necrosis factor|tumor necrosis factor-alpha|DIF-alpha|Anti-TNFSF2 / TNFa